A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies

Overview of attention for article published in BMC Pulmonary Medicine, April 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 2,175)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 38 news outlets

twitter: 3 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 43 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 38 news stories from 38 outlets.

Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases

WNCT9, 23 May 2023

– Results from the completed Collaborative Health Research Projects (CHRP) study with McMaster University presented at the…

News story from OZARKSFIRST.com on Tuesday 23 May 2023

OZARKSFIRST.com, 23 May 2023

Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases

YourErie.com, 23 May 2023

– Results from the completed Collaborative Health Research Projects (CHRP) study with McMaster University presented at the…

Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases

TriStateHomepage.com, 23 May 2023

– Results from the completed Collaborative Health Research Projects (CHRP) study with McMaster University presented at the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 34 additional news stories.